Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3056216

Cancer therapy with a parvovirus combined with bevacizumab

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    11.2.2015
  • EP published:
    1.2.2017
  • EP application number:
    15154629.8
  • Max expiry date:
    10.2.2035
  • Title:
    Cancer therapy with a parvovirus combined with bevacizumab

Timeline

Today
11.2.2015EP application
1.2.2017EP Publication

Owner

  • Name:
    Deutsches Krebsforschungszentrum
  • Address:
    Im Neuenheimer Feld 280, 69120, Heidelberg, DE
  • Name:
    Ruprecht-Karls-Universität
  • Address:
    Grabengasse 1, 69117, Heidelberg, DE

Inventor

  • Name:
    GELETNEKY, Karsten
  • Address:
    Heidelberg, DE
  • Name:
    ROMMELAERE, Jean
  • Address:
    Heidelberg, DE
  • Name:
    WICK, Wolfgang
  • Address:
    Heidelberg, DE
  • Name:
    WICK, Antje
  • Address:
    Heidelberg, DE
  • Name:
    DAHM, Michael
  • Address:
    München, DE

Classification

  • Categories:
    A61K 39/395, C07K 16/22, A61K 35/768, A61P 35/00

Upload documents